We found that blockade of estrogen nuclear receptors did not inhibit the effect of E2-BSA on activation of NF-κB p65 triggered by SLE IgG (Figure S2A in Supplementary Material). The gene discussed is NFKB1; the disease is systemic lupus erythematosus.